Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05462951
Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
Sponsor: Denise Fabian
View on ClinicalTrials.gov
Summary
This is a phase 0 clinical trial of molecular biomarkers in women with uterine cervix cancer. Women receive standard-of-care radiochemotherapy followed by brachytherapy. Blood samples are obtained to detect circulating levels of deoxyribonucleotides, human papillomavirus DNA, and circulating tumor cells.
Official title: Phase 0 Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
19
Start Date
2023-01-03
Completion Date
2025-06-09
Last Updated
2026-07-06
Healthy Volunteers
No
Conditions
Interventions
RADIATION
Standard
Radiation then brachytherapy
Locations (1)
Markey Cancer Center
Lexington, Kentucky, United States